Antigenic sites in viral pathogens exhibit distinctive evolutionary dynamics due to their role in evading recognition by host immunity. Antigenic selection is known to drive higher rates of non-synonymous substitution; less well understood is why differences are observed between viruses in their propensity to mutate to a novel or previously encountered amino acid. Here, we present a model to explain patterns of antigenic reversion and forward substitution in terms of the epidemiological and molecular processes of the viral population. We develop an analytical three-strain model and extend the analysis to a multi-site model to predict characteristics of observed sequence samples. Our model provides insight into how the balance between selection to escape immunity and to maintain viability is affected by the rate of mutational input. We also show that while low probabilities of reversion may be due to either a low cost of immune escape or slowly decaying host immunity, these two scenarios can be differentiated by the frequency patterns at antigenic sites. Comparison between frequency patterns of human influenza A (H3N2) and human RSV-A suggests that the increased rates of antigenic reversion in RSV-A is due to faster decaying immunity and not higher costs of escape.
Introduction
1 Viral evolution is shaped by both epidemiological effects on population dynamics, and molecular effects of
Methods

44
Simple analytical model for antigenic reversion
45
The simplest model containing reversion is a system where the population has mutated away from the 46 ancestral state, and potentially can mutate either back to the ancestral state (reversion) or to a novel state (forward substitution). In an epidemiological context, we consider a viral population described by a three-48 strain SIRS model [20] . The viral population is initially of strain 0 (ancestral state), which is then replaced 49 with strain 1, and can subsequently be replaced by either strain 0 (reversion) or strain 2 (forward substitution).
50
We assume a large host population of constant size N , with homogeneous mixing, so that the dynamics 51 of the number of hosts which are susceptible S i , infected I i , and recovered with immunity R i , for strains 52 i = 0, 1, 2 can be described by
with transmission rate β i , recovery rate δ, and immunity that decays at rate γ. Interactions between strains 54 are described by the implicitly defined term S i , which is the number of hosts susceptible to strain i. Assuming 55 that each host can only be infected by a single strain at a time, and prior infection with strain j reduces 56 susceptibility to strain i by a factor σ ij , the relationship between susceptible and immune hosts is given by
with the constraint that S i > 0 for any strain i. All uninfected hosts (N − j I j ) can be categorised as either 58 susceptible (S i ) or immune ( j σ ij R j ) to strain i. The similarity between this model and the status-based 59 model with polarised immunity developed by Gog and Grenfell [21] becomes evident when we differentiate 60 Equation (3) to give
1 has only just emerged and strain 2 has not yet occurred, the cross-immunity terms in Equation (3) can be 103 ignored so that it contains only terms of subscript i = 0. Substitution of Equations (5) and (6) into Equation
104
(3) gives
Now, consider a later time t 2 , when a third strain (either 0 or 2) emerges and can potentially replace strain 1.
106
Again, we assume that strain 1 remains close to equilibrium and that the third strain has had negligible effect 107 on immunity. In addition, we assume that immunity due to infection by strain 0 has decayed exponentially 108 since time t 1 , so that Equation (3) can be approximated as 
Substituting Equations (5) and (6) into (8) then gives 110 R * 1 = δN δσ 11 + γ 1 − δ β 1 − δσ 10 N σ 11 (δσ 00 + γ)
1 − δ β 0 e −γ(t2−t1) .
Having obtained an expression for R * 0 and R * 1 , we can now compute the proportion of hosts that are susceptible 111 to each strain, p i (τ ) = S i (τ )/N , where τ = t 2 − t 1 is the time since the emergence of strain 1. Thus,
which can be written in the form 113 p i (τ ) = A + B i e −γτ , for i = 0, 2.
Assuming that cross-immunity is additive with respect to the number of antigenic differences (σ ii = σ, σ 01 = 114 σ 10 = σ 21 = σ/2 and σ 20 = 0), the coefficients simplify to
Note that we expect that prior immunity reduces infection against an unmutated strain at appreciable levels 116 (σ 0.1) and that immunity lasts for much longer than the infection duration (γ δ). Within the parameter 117 range of interest, the fractional terms containing δ, σ and γ in Equations (13-15) approach constants, so that
118
A is approximately a function of only β 1 /δ and B 0 and B 2 are approximately functions of only β 0 /δ.
119
We calculate the probability of a strain generated by reversion or forward mutation at time t 2 giving rise 120 to a new epidemic by approximating the emergence of a new strain as a linear birth-death process. Ignoring 121 initial changes in host susceptibility, the probability that a new strain reaches fixation [22] is given by
where r e,i = β i p i /δ denotes the effective reproductive ratio of the new strain i at the time of emergence. Using
Equations (12-15), at time τ after strain 1 has reached equilibrium, we compute the probability of fixation for 124 strain 0 (reversion) and strain 2 (forward substitution) to be
where the threshold t c,i is given by
The probability of reversion given fixation is therefore
The probability of reversion is low immediately after the strain 0 has been replaced; in fact from Equations
128
(17-19), it is zero for τ < t c,0 . Asymptotically, if all prior immunity against strain 0 has decayed, then the 129 exponential term in the denominator of Equation (17) approaches zero, thus giving
In summary, Equation (19) describes the combined effect of immunity γ and functional constraint s on the 131 probability of reversion at some time τ after immunity has begun to wane from equilibrium levels. To verify our theoretical model, and to examine the impact of increasing the antigenic space, we develop 136 a stochastic computer simulation model where each infection is associated with a sequence of antigenic sites.
137
Population dynamics are similar to the analytical model (see Table 1 for a complete list of parameters), but 138 in the multi-site simulation, we explicitly model the mutation process. In the analytical model, we assumed 139 the emergence of three strains at specified times, and calculated the probability that these strains would reach 140 fixation. In contrast, for the simulation model, we allow mutations to occur stochastically at any antigenic 141 site throughout the simulation; thus, new strains may emerge before the old strain reaches equilibrium and 142 even favourable mutations may be lost due to stochasticity.
143
We implement two models using different representations of the antigenic space. cross-immunity, but only changes from the ancestral amino acid to a derived state will reduce transmissibility.
150
The ancestral codon sequence is determined at the beginning of each simulation by randomly sampling L a 151 non-terminating codons with uniform probability.
152
Throughout the simulation, we track the number of infected hosts I, the genotype of each infection, and the across the whole population, and we compute the immunity against any viral genotype by summing across 157 these values (described below).
158
The multi-site model is implemented as a discrete time simulation [22] , with a time-step of one day. The then calculate the probability of each potential infection i encountering a susceptible host, given by
where r vij ,j is the level of recognition against a particular antigenic site as described above. Equation 
Note that the epidemic is artificially prevented from extinction. The forcing mechanism is necessary as we 
Results
187
Using the analytical and simulation models, we examine how the epidemiology of the virus affects the 188 probability of reversion at antigenic sites. We first describe the dynamics of the simple three-strain model are temporarily reduced but p 0 slowly increases above its previous equilibrium.
206
In the first simulation [panels (a) and (c)], strain 1 is rapidly replaced with strain 2, so that at the time In Figure 2 , we show the probability of reversion as a function of τ = t 2 − t 1 , the interval between the 213 time of strain emergence (indicated by vertical grey lines in Figure 1 ). The theoretical probability of reversion
214
[Equation (19)] is compared to the proportion of reversion events in simulations with a two-site bit-string 215 model. We compute a proportion by binning substitution events with the same value of log 10 (τ ), rounded to 216 two significant figures.
217
To correspond to the analytical model, only substitution events following transitions between strain 0 to 218 strain 1 are counted. Note that in the analytical model, τ is the interval between the times of emergence; 219 however, in the simulation, it is difficult to determine which of the emerging mutations will reach fixation. As 220 a proxy for τ , the counts from the simulation are binned according to the time between antigenic substitutions 221 (i.e. the time at which a different antigenic strain becomes the dominant strain in the population).
222
These results confirm that the reversion probability varies with τ . The probability of reversion is low if 223 substitution occurs rapidly, and gradually increases with τ until it flattens at the asymptote ρ ∞ , given by 224 Equation (21). This asymptotic value represents the probability of reversion in the absence of cross-immunity.
225
The decay rate of host immunity γ affects the speed at which the asymptotic value is reached, but not the 226 value of the asymptote.
227
Greater variation is seen in the simulated results for large τ , as these represent proportions computed from 228 a smaller number of more rare events. However, the greatest discrepancy between theoretical and simulated 229 results occurs near the transition t c,0 [Equation (18)]. At τ = t c,0 , the theoretical model predicts a sharp 230 transition away from ρ(τ ) = 0; in the stochastic simulations, the transition is more gradual. The reason for 231 this discrepancy is that the theoretical model assumes that each strain reaches equilibrium before it is replaced.
232
However, in large viral populations, the mutational input rate can be large enough that strain 1 replaces strain 233 0 before I 0 can reach equilibrium. In these cases, R * 0 will be upwardly biased, so that ρ(τ ) underestimates the 234 probability of reversion. We confirm this in Figure B10 in Appendix B where a similar plot is shown ignoring The interaction between the selective cost s, and the immunity decay rate γ, is shown for a fixed τ In Sections 3.1-3.3, we observed that τ had a strong effect on whether reversions occur or not. In fact,
261
where τ is known, no further information on mutation rate µ or population size N is required. However, in
262
practice this quantity is difficult to measure. It is possible to account for variation in τ by integrating over the 263 distribution of τ , but this can remove important information; under certain parameter ranges, the stochasticity 264 of τ is sufficient to cause noticeable variation in reversion probabilities.
265
To observe the effect of fluctuations in ρ, we measure the frequency of the ancestral allele π 0 at each 266 antigenic site. The frequency of an allele is informative about its fixation probability [26] , and the rate of 
271
In Figure 5 , we show frequency trajectories π 0 , under conditions of both antigenic selection and selective 272 constraint, so that antigenic changes away from the ancestral sequence imposes a cost. To account for in-
273
accuracies due to sampling, π 0 was computed from sequences sampled at discrete intervals, and the earliest 274 sequence sampled after the burn-in period was used as the ancestral sequence. In all panels, we observe fluctu- 
Application to influenza and RSV
292
In Figure 7 , we show π 0 changing over time for the human influenza A virus subtype H3N2 and the 
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. All simulations were run with γ = 1 × 10 −3 day −1 , β = 1.0 day −1 , δ = 0.2 day −1 , µ = 10 −5 site −1 day −1 , and La = 7.
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. We implement two agent-based simulations which differ in how they model the decay of host immunity. In 528 model A1, immunity decays deterministically, so there is no variability in the rate of decay between hosts. In 529 contrast, in model A2, we maximise the variability in the rate of decay by having complete loss of immunity 530 in a proportion of hosts. In both models, population-wide levels of immunity are reduced, but there are 531 considerable differences in the variation in levels of immunity between hosts, which is known to affect the suggesting that derivations of ρ(τ ) remain valid. However, differences can be seen in equilibrium value of I.
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The compartmental model equilibrates at a lower mean value of I compared to both agent-based models A1 547 and A2, with a larger difference when compared to A1 (Figure A.9) . However, this discrepancy is comparable 
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